nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—CYP3A4—bone cancer	0.524	1	CbGaD
Dronabinol—ABCG2—Carboplatin—bone cancer	0.0921	0.242	CbGbCtD
Dronabinol—ABCG2—Cisplatin—bone cancer	0.0787	0.207	CbGbCtD
Dronabinol—ABCG2—Doxorubicin—bone cancer	0.0527	0.138	CbGbCtD
Dronabinol—ABCG2—Methotrexate—bone cancer	0.0511	0.134	CbGbCtD
Dronabinol—CYP2C9—Cisplatin—bone cancer	0.0292	0.0767	CbGbCtD
Dronabinol—ABCB1—Cisplatin—bone cancer	0.0284	0.0745	CbGbCtD
Dronabinol—ABCB1—Doxorubicin—bone cancer	0.019	0.0499	CbGbCtD
Dronabinol—ABCB1—Methotrexate—bone cancer	0.0184	0.0483	CbGbCtD
Dronabinol—CYP3A4—Doxorubicin—bone cancer	0.0114	0.0299	CbGbCtD
Dronabinol—CNR1—GPCRs, Other—GRM1—bone cancer	0.00162	0.0233	CbGpPWpGaD
Dronabinol—Speech impairment NOS—Methotrexate—bone cancer	0.0016	0.0625	CcSEcCtD
Dronabinol—CYP1A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00143	0.0205	CbGpPWpGaD
Dronabinol—ABCG2—Irinotecan Pathway—CYP3A4—bone cancer	0.00136	0.0195	CbGpPWpGaD
Dronabinol—CYP1A1—Benzo(a)pyrene metabolism—CYP3A4—bone cancer	0.00131	0.0188	CbGpPWpGaD
Dronabinol—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00117	0.0168	CbGpPWpGaD
Dronabinol—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00115	0.0165	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Other—SMO—bone cancer	0.00114	0.0164	CbGpPWpGaD
Dronabinol—CNR2—G alpha (i) signalling events—RGS1—bone cancer	0.00112	0.016	CbGpPWpGaD
Dronabinol—CNR2—G alpha (i) signalling events—GRM4—bone cancer	0.00112	0.016	CbGpPWpGaD
Dronabinol—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00111	0.0159	CbGpPWpGaD
Dronabinol—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00107	0.0154	CbGpPWpGaD
Dronabinol—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00107	0.0154	CbGpPWpGaD
Dronabinol—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00107	0.0153	CbGpPWpGaD
Dronabinol—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00102	0.0146	CbGpPWpGaD
Dronabinol—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.000925	0.0133	CbGpPWpGaD
Dronabinol—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00089	0.0128	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—GRM4—bone cancer	0.000876	0.0126	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—RGS1—bone cancer	0.000876	0.0126	CbGpPWpGaD
Dronabinol—CNR1—BDNF signaling pathway—EIF2S1—bone cancer	0.00083	0.0119	CbGpPWpGaD
Dronabinol—CYP1A1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000824	0.0118	CbGpPWpGaD
Dronabinol—ABCG2—Fluoropyrimidine Activity—DHFR—bone cancer	0.000805	0.0116	CbGpPWpGaD
Dronabinol—CYP1A1—Estrogen metabolism—CYP3A4—bone cancer	0.00075	0.0108	CbGpPWpGaD
Dronabinol—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.000732	0.0105	CbGpPWpGaD
Dronabinol—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000703	0.0101	CbGpPWpGaD
Dronabinol—CYP1A1—Xenobiotics—CYP3A4—bone cancer	0.00069	0.00991	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—GRM4—bone cancer	0.000676	0.00971	CbGpPWpGaD
Dronabinol—CYP1A1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000663	0.00953	CbGpPWpGaD
Dronabinol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000661	0.0095	CbGpPWpGaD
Dronabinol—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000635	0.00913	CbGpPWpGaD
Dronabinol—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000627	0.00901	CbGpPWpGaD
Dronabinol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000617	0.00886	CbGpPWpGaD
Dronabinol—CYP1A1—Metapathway biotransformation—CYP4V2—bone cancer	0.000615	0.00884	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—GRM1—bone cancer	0.000586	0.00842	CbGpPWpGaD
Dronabinol—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	0.000577	0.00829	CbGpPWpGaD
Dronabinol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000576	0.00828	CbGpPWpGaD
Dronabinol—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000564	0.00811	CbGpPWpGaD
Dronabinol—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000543	0.0078	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—GRM4—bone cancer	0.00053	0.00762	CbGpPWpGaD
Dronabinol—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000515	0.00739	CbGpPWpGaD
Dronabinol—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000503	0.00723	CbGpPWpGaD
Dronabinol—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000495	0.00711	CbGpPWpGaD
Dronabinol—Amnesia—Cisplatin—bone cancer	0.000492	0.0192	CcSEcCtD
Dronabinol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.00049	0.00704	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—GRM1—bone cancer	0.00046	0.00661	CbGpPWpGaD
Dronabinol—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000459	0.00659	CbGpPWpGaD
Dronabinol—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000452	0.00649	CbGpPWpGaD
Dronabinol—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000442	0.00635	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—SMO—bone cancer	0.000413	0.00593	CbGpPWpGaD
Dronabinol—Speech disorder—Methotrexate—bone cancer	0.000407	0.0159	CcSEcCtD
Dronabinol—CYP1A1—Estrogen Receptor Pathway—JUN—bone cancer	0.000389	0.00559	CbGpPWpGaD
Dronabinol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000387	0.00557	CbGpPWpGaD
Dronabinol—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000384	0.00552	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—RGS1—bone cancer	0.000382	0.00549	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—GRM4—bone cancer	0.000382	0.00549	CbGpPWpGaD
Dronabinol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00038	0.00546	CbGpPWpGaD
Dronabinol—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000379	0.00545	CbGpPWpGaD
Dronabinol—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000378	0.00543	CbGpPWpGaD
Dronabinol—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.000375	0.00539	CbGpPWpGaD
Dronabinol—Vasodilation procedure—Epirubicin—bone cancer	0.000372	0.0145	CcSEcCtD
Dronabinol—Vasodilation—Epirubicin—bone cancer	0.000372	0.0145	CcSEcCtD
Dronabinol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00036	0.00518	CbGpPWpGaD
Dronabinol—Thinking abnormal—Epirubicin—bone cancer	0.000357	0.014	CcSEcCtD
Dronabinol—CYP1A1—Tryptophan metabolism—CYP3A4—bone cancer	0.000354	0.00509	CbGpPWpGaD
Dronabinol—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000353	0.00508	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—RGS1—bone cancer	0.000347	0.00498	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—GRM4—bone cancer	0.000347	0.00498	CbGpPWpGaD
Dronabinol—Conjunctivitis—Cisplatin—bone cancer	0.000347	0.0135	CcSEcCtD
Dronabinol—Vasodilation procedure—Doxorubicin—bone cancer	0.000345	0.0135	CcSEcCtD
Dronabinol—Vasodilation—Doxorubicin—bone cancer	0.000345	0.0135	CcSEcCtD
Dronabinol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000337	0.00484	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—GRM1—bone cancer	0.000331	0.00476	CbGpPWpGaD
Dronabinol—Thinking abnormal—Doxorubicin—bone cancer	0.000331	0.0129	CcSEcCtD
Dronabinol—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000329	0.00473	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—SMO—bone cancer	0.000324	0.00465	CbGpPWpGaD
Dronabinol—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000314	0.00451	CbGpPWpGaD
Dronabinol—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000312	0.00448	CbGpPWpGaD
Dronabinol—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000303	0.00435	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—GRM1—bone cancer	0.000301	0.00432	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—GRM4—bone cancer	0.0003	0.00431	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—RGS1—bone cancer	0.0003	0.00431	CbGpPWpGaD
Dronabinol—Tinnitus—Cisplatin—bone cancer	0.000298	0.0117	CcSEcCtD
Dronabinol—Flushing—Cisplatin—bone cancer	0.000297	0.0116	CcSEcCtD
Dronabinol—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.00029	0.00417	CbGpPWpGaD
Dronabinol—Immune system disorder—Cisplatin—bone cancer	0.000289	0.0113	CcSEcCtD
Dronabinol—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000286	0.00411	CbGpPWpGaD
Dronabinol—Mental disability—Epirubicin—bone cancer	0.000284	0.0111	CcSEcCtD
Dronabinol—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000283	0.00406	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—GRM4—bone cancer	0.000272	0.00391	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—RGS1—bone cancer	0.000272	0.00391	CbGpPWpGaD
Dronabinol—Mental disability—Doxorubicin—bone cancer	0.000263	0.0103	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—JUN—bone cancer	0.000262	0.00377	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—GRM1—bone cancer	0.00026	0.00373	CbGpPWpGaD
Dronabinol—Ill-defined disorder—Cisplatin—bone cancer	0.000258	0.0101	CcSEcCtD
Dronabinol—Malaise—Cisplatin—bone cancer	0.000251	0.00981	CcSEcCtD
Dronabinol—Convulsion—Cisplatin—bone cancer	0.000241	0.00942	CcSEcCtD
Dronabinol—Ataxia—Methotrexate—bone cancer	0.000239	0.00932	CcSEcCtD
Dronabinol—Myalgia—Cisplatin—bone cancer	0.000237	0.00926	CcSEcCtD
Dronabinol—Anxiety—Cisplatin—bone cancer	0.000236	0.00923	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—GRM1—bone cancer	0.000236	0.00339	CbGpPWpGaD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000236	0.0092	CcSEcCtD
Dronabinol—Discomfort—Cisplatin—bone cancer	0.000234	0.00915	CcSEcCtD
Dronabinol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000234	0.00337	CbGpPWpGaD
Dronabinol—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000232	0.00334	CbGpPWpGaD
Dronabinol—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000231	0.00332	CbGpPWpGaD
Dronabinol—Ataxia—Epirubicin—bone cancer	0.000223	0.00872	CcSEcCtD
Dronabinol—Nervous system disorder—Cisplatin—bone cancer	0.000223	0.00871	CcSEcCtD
Dronabinol—Tachycardia—Cisplatin—bone cancer	0.000222	0.00866	CcSEcCtD
Dronabinol—Skin disorder—Cisplatin—bone cancer	0.000221	0.00862	CcSEcCtD
Dronabinol—Hyperhidrosis—Cisplatin—bone cancer	0.00022	0.00858	CcSEcCtD
Dronabinol—Anorexia—Cisplatin—bone cancer	0.000217	0.00846	CcSEcCtD
Dronabinol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000214	0.00307	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—GNA11—bone cancer	0.000213	0.00307	CbGpPWpGaD
Dronabinol—Hypotension—Cisplatin—bone cancer	0.000212	0.0083	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—SMO—bone cancer	0.000212	0.00304	CbGpPWpGaD
Dronabinol—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000211	0.00303	CbGpPWpGaD
Dronabinol—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000208	0.00299	CbGpPWpGaD
Dronabinol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000207	0.00809	CcSEcCtD
Dronabinol—Ataxia—Doxorubicin—bone cancer	0.000207	0.00807	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—RGS1—bone cancer	0.000205	0.00294	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—GRM4—bone cancer	0.000205	0.00294	CbGpPWpGaD
Dronabinol—Decreased appetite—Cisplatin—bone cancer	0.000198	0.00772	CcSEcCtD
Dronabinol—Drowsiness—Methotrexate—bone cancer	0.000196	0.00764	CcSEcCtD
Dronabinol—Depression—Methotrexate—bone cancer	0.000195	0.00762	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—GNA11—bone cancer	0.000194	0.00278	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—IL3—bone cancer	0.000193	0.00278	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000191	0.00274	CbGpPWpGaD
Dronabinol—Conjunctivitis—Methotrexate—bone cancer	0.00019	0.00742	CcSEcCtD
Dronabinol—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00019	0.00273	CbGpPWpGaD
Dronabinol—Sweating—Methotrexate—bone cancer	0.000188	0.00732	CcSEcCtD
Dronabinol—Feeling abnormal—Cisplatin—bone cancer	0.000187	0.00732	CcSEcCtD
Dronabinol—Drowsiness—Epirubicin—bone cancer	0.000183	0.00715	CcSEcCtD
Dronabinol—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	0.00018	0.00259	CbGpPWpGaD
Dronabinol—Conjunctivitis—Epirubicin—bone cancer	0.000178	0.00695	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—GRM1—bone cancer	0.000178	0.00255	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—IL3—bone cancer	0.000176	0.00252	CbGpPWpGaD
Dronabinol—Sweating—Epirubicin—bone cancer	0.000176	0.00685	CcSEcCtD
Dronabinol—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000175	0.00251	CbGpPWpGaD
Dronabinol—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000173	0.00249	CbGpPWpGaD
Dronabinol—Sinusitis—Epirubicin—bone cancer	0.000172	0.00671	CcSEcCtD
Dronabinol—Drowsiness—Doxorubicin—bone cancer	0.000169	0.00661	CcSEcCtD
Dronabinol—Hypersensitivity—Cisplatin—bone cancer	0.000168	0.00654	CcSEcCtD
Dronabinol—CNR1—GPCR downstream signaling—GNA11—bone cancer	0.000167	0.00241	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—SMO—bone cancer	0.000166	0.00239	CbGpPWpGaD
Dronabinol—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000165	0.00238	CbGpPWpGaD
Dronabinol—Rhinitis—Epirubicin—bone cancer	0.000165	0.00643	CcSEcCtD
Dronabinol—Conjunctivitis—Doxorubicin—bone cancer	0.000165	0.00643	CcSEcCtD
Dronabinol—Tinnitus—Methotrexate—bone cancer	0.000164	0.00639	CcSEcCtD
Dronabinol—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000164	0.00235	CbGpPWpGaD
Dronabinol—Asthenia—Cisplatin—bone cancer	0.000163	0.00637	CcSEcCtD
Dronabinol—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	0.000163	0.00234	CbGpPWpGaD
Dronabinol—Sweating—Doxorubicin—bone cancer	0.000162	0.00634	CcSEcCtD
Dronabinol—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000161	0.00232	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000161	0.00232	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—GRM4—bone cancer	0.000161	0.00231	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—RGS1—bone cancer	0.000161	0.00231	CbGpPWpGaD
Dronabinol—Sinusitis—Doxorubicin—bone cancer	0.000159	0.00621	CcSEcCtD
Dronabinol—Immune system disorder—Methotrexate—bone cancer	0.000159	0.00619	CcSEcCtD
Dronabinol—Chills—Methotrexate—bone cancer	0.000158	0.00615	CcSEcCtD
Dronabinol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000157	0.00226	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000157	0.00225	CbGpPWpGaD
Dronabinol—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000157	0.00225	CbGpPWpGaD
Dronabinol—Diarrhoea—Cisplatin—bone cancer	0.000156	0.00607	CcSEcCtD
Dronabinol—Tinnitus—Epirubicin—bone cancer	0.000153	0.00598	CcSEcCtD
Dronabinol—Flushing—Epirubicin—bone cancer	0.000153	0.00596	CcSEcCtD
Dronabinol—Rhinitis—Doxorubicin—bone cancer	0.000152	0.00595	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—GNA11—bone cancer	0.000152	0.00218	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—IL3—bone cancer	0.000152	0.00218	CbGpPWpGaD
Dronabinol—PTGS1—Biological oxidations—GSTP1—bone cancer	0.00015	0.00215	CbGpPWpGaD
Dronabinol—Immune system disorder—Epirubicin—bone cancer	0.000148	0.0058	CcSEcCtD
Dronabinol—Chills—Epirubicin—bone cancer	0.000147	0.00576	CcSEcCtD
Dronabinol—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000147	0.00211	CbGpPWpGaD
Dronabinol—Rash—Cisplatin—bone cancer	0.000143	0.0056	CcSEcCtD
Dronabinol—Dermatitis—Cisplatin—bone cancer	0.000143	0.00559	CcSEcCtD
Dronabinol—Ill-defined disorder—Methotrexate—bone cancer	0.000142	0.00554	CcSEcCtD
Dronabinol—Tinnitus—Doxorubicin—bone cancer	0.000142	0.00554	CcSEcCtD
Dronabinol—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000142	0.00203	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000141	0.00203	CbGpPWpGaD
Dronabinol—Flushing—Doxorubicin—bone cancer	0.000141	0.00551	CcSEcCtD
Dronabinol—Tension—Epirubicin—bone cancer	0.00014	0.00548	CcSEcCtD
Dronabinol—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00014	0.00201	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—GRM1—bone cancer	0.000139	0.002	CbGpPWpGaD
Dronabinol—Nervousness—Epirubicin—bone cancer	0.000139	0.00543	CcSEcCtD
Dronabinol—Malaise—Methotrexate—bone cancer	0.000138	0.00538	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—IL3—bone cancer	0.000138	0.00198	CbGpPWpGaD
Dronabinol—Immune system disorder—Doxorubicin—bone cancer	0.000137	0.00536	CcSEcCtD
Dronabinol—Chills—Doxorubicin—bone cancer	0.000136	0.00533	CcSEcCtD
Dronabinol—Cough—Methotrexate—bone cancer	0.000133	0.00521	CcSEcCtD
Dronabinol—Ill-defined disorder—Epirubicin—bone cancer	0.000133	0.00518	CcSEcCtD
Dronabinol—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000133	0.0019	CbGpPWpGaD
Dronabinol—Convulsion—Methotrexate—bone cancer	0.000132	0.00517	CcSEcCtD
Dronabinol—Myalgia—Methotrexate—bone cancer	0.00013	0.00508	CcSEcCtD
Dronabinol—Tension—Doxorubicin—bone cancer	0.00013	0.00507	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000129	0.00505	CcSEcCtD
Dronabinol—Malaise—Epirubicin—bone cancer	0.000129	0.00504	CcSEcCtD
Dronabinol—Discomfort—Methotrexate—bone cancer	0.000129	0.00502	CcSEcCtD
Dronabinol—Nervousness—Doxorubicin—bone cancer	0.000129	0.00502	CcSEcCtD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000128	0.00185	CbGpPWpGaD
Dronabinol—Palpitations—Epirubicin—bone cancer	0.000126	0.00494	CcSEcCtD
Dronabinol—Confusional state—Methotrexate—bone cancer	0.000126	0.00491	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—SMO—bone cancer	0.000125	0.0018	CbGpPWpGaD
Dronabinol—Cough—Epirubicin—bone cancer	0.000125	0.00487	CcSEcCtD
Dronabinol—Convulsion—Epirubicin—bone cancer	0.000124	0.00484	CcSEcCtD
Dronabinol—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.000123	0.00177	CbGpPWpGaD
Dronabinol—Ill-defined disorder—Doxorubicin—bone cancer	0.000123	0.0048	CcSEcCtD
Dronabinol—Nervous system disorder—Methotrexate—bone cancer	0.000122	0.00478	CcSEcCtD
Dronabinol—Myalgia—Epirubicin—bone cancer	0.000122	0.00476	CcSEcCtD
Dronabinol—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000122	0.00175	CbGpPWpGaD
Dronabinol—Anxiety—Epirubicin—bone cancer	0.000121	0.00474	CcSEcCtD
Dronabinol—Skin disorder—Methotrexate—bone cancer	0.000121	0.00473	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000121	0.00472	CcSEcCtD
Dronabinol—Hyperhidrosis—Methotrexate—bone cancer	0.000121	0.00471	CcSEcCtD
Dronabinol—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000121	0.00173	CbGpPWpGaD
Dronabinol—Discomfort—Epirubicin—bone cancer	0.00012	0.0047	CcSEcCtD
Dronabinol—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.00012	0.00173	CbGpPWpGaD
Dronabinol—Malaise—Doxorubicin—bone cancer	0.000119	0.00466	CcSEcCtD
Dronabinol—Dry mouth—Epirubicin—bone cancer	0.000119	0.00465	CcSEcCtD
Dronabinol—Anorexia—Methotrexate—bone cancer	0.000119	0.00464	CcSEcCtD
Dronabinol—Confusional state—Epirubicin—bone cancer	0.000118	0.0046	CcSEcCtD
Dronabinol—Palpitations—Doxorubicin—bone cancer	0.000117	0.00457	CcSEcCtD
Dronabinol—Hypotension—Methotrexate—bone cancer	0.000117	0.00455	CcSEcCtD
Dronabinol—Cough—Doxorubicin—bone cancer	0.000116	0.00451	CcSEcCtD
Dronabinol—Convulsion—Doxorubicin—bone cancer	0.000115	0.00448	CcSEcCtD
Dronabinol—Nervous system disorder—Epirubicin—bone cancer	0.000115	0.00447	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—GNA11—bone cancer	0.000114	0.00164	CbGpPWpGaD
Dronabinol—Tachycardia—Epirubicin—bone cancer	0.000114	0.00445	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000114	0.00444	CcSEcCtD
Dronabinol—Skin disorder—Epirubicin—bone cancer	0.000113	0.00443	CcSEcCtD
Dronabinol—Hyperhidrosis—Epirubicin—bone cancer	0.000113	0.00441	CcSEcCtD
Dronabinol—Myalgia—Doxorubicin—bone cancer	0.000113	0.0044	CcSEcCtD
Dronabinol—Anxiety—Doxorubicin—bone cancer	0.000112	0.00439	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000112	0.00437	CcSEcCtD
Dronabinol—Discomfort—Doxorubicin—bone cancer	0.000111	0.00435	CcSEcCtD
Dronabinol—Anorexia—Epirubicin—bone cancer	0.000111	0.00435	CcSEcCtD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000111	0.0016	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000111	0.0016	CbGpPWpGaD
Dronabinol—Somnolence—Methotrexate—bone cancer	0.000111	0.00433	CcSEcCtD
Dronabinol—Dry mouth—Doxorubicin—bone cancer	0.00011	0.0043	CcSEcCtD
Dronabinol—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.00011	0.00157	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000109	0.00157	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—NDUFA12—bone cancer	0.000109	0.00157	CbGpPWpGaD
Dronabinol—Hypotension—Epirubicin—bone cancer	0.000109	0.00426	CcSEcCtD
Dronabinol—Confusional state—Doxorubicin—bone cancer	0.000109	0.00425	CcSEcCtD
Dronabinol—Decreased appetite—Methotrexate—bone cancer	0.000108	0.00423	CcSEcCtD
Dronabinol—Fatigue—Methotrexate—bone cancer	0.000108	0.0042	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—ATF1—bone cancer	0.000106	0.00153	CbGpPWpGaD
Dronabinol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000106	0.00415	CcSEcCtD
Dronabinol—Nervous system disorder—Doxorubicin—bone cancer	0.000106	0.00414	CcSEcCtD
Dronabinol—CYP1A1—Biological oxidations—GSTP1—bone cancer	0.000105	0.00152	CbGpPWpGaD
Dronabinol—Tachycardia—Doxorubicin—bone cancer	0.000105	0.00412	CcSEcCtD
Dronabinol—Skin disorder—Doxorubicin—bone cancer	0.000105	0.0041	CcSEcCtD
Dronabinol—PTGS1—Metabolism—NDUFA12—bone cancer	0.000105	0.00151	CbGpPWpGaD
Dronabinol—Hyperhidrosis—Doxorubicin—bone cancer	0.000104	0.00408	CcSEcCtD
Dronabinol—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000104	0.00149	CbGpPWpGaD
Dronabinol—Somnolence—Epirubicin—bone cancer	0.000104	0.00405	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—IL3—bone cancer	0.000104	0.00149	CbGpPWpGaD
Dronabinol—Anorexia—Doxorubicin—bone cancer	0.000103	0.00402	CcSEcCtD
Dronabinol—Feeling abnormal—Methotrexate—bone cancer	0.000103	0.00401	CcSEcCtD
Dronabinol—Gastrointestinal pain—Methotrexate—bone cancer	0.000102	0.00398	CcSEcCtD
Dronabinol—Decreased appetite—Epirubicin—bone cancer	0.000101	0.00396	CcSEcCtD
Dronabinol—Hypotension—Doxorubicin—bone cancer	0.000101	0.00394	CcSEcCtD
Dronabinol—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000101	0.00145	CbGpPWpGaD
Dronabinol—Fatigue—Epirubicin—bone cancer	0.000101	0.00393	CcSEcCtD
Dronabinol—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	9.95e-05	0.00143	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.95e-05	0.00143	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—NDUFA12—bone cancer	9.92e-05	0.00143	CbGpPWpGaD
Dronabinol—Abdominal pain—Methotrexate—bone cancer	9.86e-05	0.00385	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.84e-05	0.00384	CcSEcCtD
Dronabinol—CNR1—Signaling Pathways—SMO—bone cancer	9.82e-05	0.00141	CbGpPWpGaD
Dronabinol—Feeling abnormal—Epirubicin—bone cancer	9.62e-05	0.00376	CcSEcCtD
Dronabinol—Somnolence—Doxorubicin—bone cancer	9.6e-05	0.00375	CcSEcCtD
Dronabinol—Gastrointestinal pain—Epirubicin—bone cancer	9.55e-05	0.00373	CcSEcCtD
Dronabinol—Decreased appetite—Doxorubicin—bone cancer	9.39e-05	0.00367	CcSEcCtD
Dronabinol—Fatigue—Doxorubicin—bone cancer	9.31e-05	0.00364	CcSEcCtD
Dronabinol—Abdominal pain—Epirubicin—bone cancer	9.23e-05	0.0036	CcSEcCtD
Dronabinol—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.2e-05	0.00132	CbGpPWpGaD
Dronabinol—Hypersensitivity—Methotrexate—bone cancer	9.19e-05	0.00359	CcSEcCtD
Dronabinol—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.07e-05	0.0013	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.06e-05	0.0013	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—NT5C3A—bone cancer	9.05e-05	0.0013	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—GNA11—bone cancer	8.98e-05	0.00129	CbGpPWpGaD
Dronabinol—Asthenia—Methotrexate—bone cancer	8.95e-05	0.0035	CcSEcCtD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.93e-05	0.00128	CbGpPWpGaD
Dronabinol—Feeling abnormal—Doxorubicin—bone cancer	8.9e-05	0.00348	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—TGFBR2—bone cancer	8.87e-05	0.00128	CbGpPWpGaD
Dronabinol—Gastrointestinal pain—Doxorubicin—bone cancer	8.83e-05	0.00345	CcSEcCtD
Dronabinol—Pruritus—Methotrexate—bone cancer	8.83e-05	0.00345	CcSEcCtD
Dronabinol—PTGS1—Metabolism—NT5C3A—bone cancer	8.69e-05	0.00125	CbGpPWpGaD
Dronabinol—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.63e-05	0.00124	CbGpPWpGaD
Dronabinol—Hypersensitivity—Epirubicin—bone cancer	8.6e-05	0.00336	CcSEcCtD
Dronabinol—Abdominal pain—Doxorubicin—bone cancer	8.54e-05	0.00333	CcSEcCtD
Dronabinol—Diarrhoea—Methotrexate—bone cancer	8.54e-05	0.00333	CcSEcCtD
Dronabinol—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.51e-05	0.00122	CbGpPWpGaD
Dronabinol—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.47e-05	0.00122	CbGpPWpGaD
Dronabinol—Asthenia—Epirubicin—bone cancer	8.38e-05	0.00327	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—IGF1R—bone cancer	8.35e-05	0.0012	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—ATF1—bone cancer	8.35e-05	0.0012	CbGpPWpGaD
Dronabinol—Pruritus—Epirubicin—bone cancer	8.26e-05	0.00323	CcSEcCtD
Dronabinol—Dizziness—Methotrexate—bone cancer	8.25e-05	0.00322	CcSEcCtD
Dronabinol—CYP2A6—Metabolism—NT5C3A—bone cancer	8.22e-05	0.00118	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL3—bone cancer	8.14e-05	0.00117	CbGpPWpGaD
Dronabinol—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.01e-05	0.00115	CbGpPWpGaD
Dronabinol—Diarrhoea—Epirubicin—bone cancer	7.99e-05	0.00312	CcSEcCtD
Dronabinol—Hypersensitivity—Doxorubicin—bone cancer	7.96e-05	0.00311	CcSEcCtD
Dronabinol—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.87e-05	0.00113	CbGpPWpGaD
Dronabinol—Rash—Methotrexate—bone cancer	7.87e-05	0.00307	CcSEcCtD
Dronabinol—Dermatitis—Methotrexate—bone cancer	7.86e-05	0.00307	CcSEcCtD
Dronabinol—Headache—Methotrexate—bone cancer	7.82e-05	0.00305	CcSEcCtD
Dronabinol—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.76e-05	0.00112	CbGpPWpGaD
Dronabinol—Asthenia—Doxorubicin—bone cancer	7.75e-05	0.00303	CcSEcCtD
Dronabinol—Dizziness—Epirubicin—bone cancer	7.72e-05	0.00301	CcSEcCtD
Dronabinol—Pruritus—Doxorubicin—bone cancer	7.64e-05	0.00298	CcSEcCtD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.57e-05	0.00109	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.55e-05	0.00108	CbGpPWpGaD
Dronabinol—Diarrhoea—Doxorubicin—bone cancer	7.39e-05	0.00289	CcSEcCtD
Dronabinol—CYP1A1—Metabolism—NDUFA12—bone cancer	7.39e-05	0.00106	CbGpPWpGaD
Dronabinol—Rash—Epirubicin—bone cancer	7.36e-05	0.00287	CcSEcCtD
Dronabinol—Dermatitis—Epirubicin—bone cancer	7.35e-05	0.00287	CcSEcCtD
Dronabinol—Headache—Epirubicin—bone cancer	7.31e-05	0.00286	CcSEcCtD
Dronabinol—Dizziness—Doxorubicin—bone cancer	7.14e-05	0.00279	CcSEcCtD
Dronabinol—CNR1—Signaling Pathways—TGFBR2—bone cancer	6.96e-05	0.001	CbGpPWpGaD
Dronabinol—Rash—Doxorubicin—bone cancer	6.81e-05	0.00266	CcSEcCtD
Dronabinol—Dermatitis—Doxorubicin—bone cancer	6.81e-05	0.00266	CcSEcCtD
Dronabinol—Headache—Doxorubicin—bone cancer	6.77e-05	0.00264	CcSEcCtD
Dronabinol—CNR1—Signaling Pathways—IGF1R—bone cancer	6.55e-05	0.000941	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.52e-05	0.000937	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—NT5C3A—bone cancer	6.12e-05	0.00088	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—KIT—bone cancer	6.06e-05	0.00087	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—NDUFA12—bone cancer	6.05e-05	0.000869	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—NDUFA12—bone cancer	5.9e-05	0.000848	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—BRAF—bone cancer	5.69e-05	0.000818	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.61e-05	0.000807	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—EGFR—bone cancer	5.52e-05	0.000793	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—NDUFA12—bone cancer	5.51e-05	0.000792	CbGpPWpGaD
Dronabinol—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.19e-05	0.000746	CbGpPWpGaD
Dronabinol—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.12e-05	0.000735	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—NT5C3A—bone cancer	5.01e-05	0.00072	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—NT5C3A—bone cancer	4.89e-05	0.000703	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MDM2—bone cancer	4.77e-05	0.000685	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—KIT—bone cancer	4.75e-05	0.000683	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—NT5C3A—bone cancer	4.57e-05	0.000657	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—BRAF—bone cancer	4.47e-05	0.000642	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—EGFR—bone cancer	4.33e-05	0.000622	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.16e-05	0.000598	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—JUN—bone cancer	4.14e-05	0.000596	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MMP9—bone cancer	4.03e-05	0.000579	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.01e-05	0.000577	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ENO2—bone cancer	3.96e-05	0.000569	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ENO2—bone cancer	3.81e-05	0.000547	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MDM2—bone cancer	3.74e-05	0.000538	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—DHFR—bone cancer	3.68e-05	0.000528	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—NDUFA12—bone cancer	3.64e-05	0.000523	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.62e-05	0.00052	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ENO2—bone cancer	3.6e-05	0.000517	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—DHFR—bone cancer	3.53e-05	0.000508	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GNA11—bone cancer	3.44e-05	0.000494	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—DHFR—bone cancer	3.34e-05	0.00048	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GNA11—bone cancer	3.3e-05	0.000474	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—EGFR—bone cancer	3.26e-05	0.000468	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—JUN—bone cancer	3.25e-05	0.000467	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MMP9—bone cancer	3.16e-05	0.000455	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GNA11—bone cancer	3.12e-05	0.000449	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—CYP3A4—bone cancer	3.12e-05	0.000448	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—NT5C3A—bone cancer	3.01e-05	0.000433	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—CYP3A4—bone cancer	2.99e-05	0.00043	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.98e-05	0.000428	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.84e-05	0.000409	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—CYP3A4—bone cancer	2.83e-05	0.000407	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—TP53—bone cancer	2.74e-05	0.000393	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ENO2—bone cancer	2.68e-05	0.000385	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GSTP1—bone cancer	2.66e-05	0.000383	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GSTP1—bone cancer	2.56e-05	0.000368	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—EGFR—bone cancer	2.56e-05	0.000367	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—DHFR—bone cancer	2.49e-05	0.000358	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GSTP1—bone cancer	2.42e-05	0.000348	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.39e-05	0.000343	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GNA11—bone cancer	2.33e-05	0.000334	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ENO2—bone cancer	2.2e-05	0.000315	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—TP53—bone cancer	2.15e-05	0.000309	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ENO2—bone cancer	2.14e-05	0.000308	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—CYP3A4—bone cancer	2.11e-05	0.000303	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.1e-05	0.000301	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—DHFR—bone cancer	2.04e-05	0.000293	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ENO2—bone cancer	2e-05	0.000288	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—DHFR—bone cancer	1.99e-05	0.000286	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GNA11—bone cancer	1.9e-05	0.000273	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GNA11—bone cancer	1.86e-05	0.000267	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—DHFR—bone cancer	1.86e-05	0.000267	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GSTP1—bone cancer	1.8e-05	0.000259	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GNA11—bone cancer	1.74e-05	0.000249	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—CYP3A4—bone cancer	1.73e-05	0.000248	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.72e-05	0.000247	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000242	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—CYP3A4—bone cancer	1.57e-05	0.000226	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.57e-05	0.000225	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GSTP1—bone cancer	1.48e-05	0.000212	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GSTP1—bone cancer	1.44e-05	0.000207	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PTGS2—bone cancer	1.38e-05	0.000198	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GSTP1—bone cancer	1.35e-05	0.000193	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PTGS2—bone cancer	1.33e-05	0.000191	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ENO2—bone cancer	1.32e-05	0.00019	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PTGS2—bone cancer	1.25e-05	0.00018	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—DHFR—bone cancer	1.22e-05	0.000176	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GNA11—bone cancer	1.14e-05	0.000164	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PTGS2—bone cancer	9.34e-06	0.000134	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GSTP1—bone cancer	8.87e-06	0.000128	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PTGS2—bone cancer	7.65e-06	0.00011	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PTGS2—bone cancer	7.46e-06	0.000107	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PTGS2—bone cancer	6.97e-06	0.0001	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PTGS2—bone cancer	4.6e-06	6.61e-05	CbGpPWpGaD
